Biocon Limited Max Pain Analysis
What is Max Pain?
Max Pain theory states the underlying gravitates toward the strike where option writers face minimum collective loss at expiry. For BIOCON, that strike is ₹410. Spot at ₹397.4 is 3.1% below max pain — possible upward gravitational pull into expiry.
Max Pain Level
The current max‑pain strike for Biocon Limited (BIOCON) is ₹410. This is the strike at which option writers would incur the smallest aggregate loss, so the price tends to be magnetized toward it as expiry approaches.
Spot vs Max Pain Gap
The spot price of ₹397.4 sits about 3.1 % below the max‑pain level, indicating a modest upside pull‑toward the ₹410 strike. The gap suggests that, all else equal, the underlying may experience upward pressure as the expiration date nears.
Shift Signal
There is no shift in the max‑pain level from the previous day, implying that option writers have not altered their positioning materially. A stable max‑pain figure often reflects a lack of new hedging activity and reinforces the existing magnet effect.
Expiry Context
Max pain is derived by aggregating the open‑interest of all calls and puts and identifying the strike that minimizes total writer loss at expiry. Historically, during the final week before expiry, the underlying price frequently gravitates toward this strike, though the phenomenon is a statistical tendency rather than a deterministic outcome.
Data Note
Biocon’s spot price is ₹12.6 below the max‑pain strike of ₹410, with 25 trading days remaining until the 2026‑09‑29 expiration.
Data as of 2026-09-04